Sign in
CompletedNo phase

Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy

Key facts

Who runs it
University Hospital, Bordeaux
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
72 people enrolled
Started
17 Jul 2023
Ended
3 Apr 2026
Type of study
Interventional
Treatments tested
  • questionnaire
Record updated
29 June 2026

Who can take part

Age
18 years to 40 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • positive diagnosis of POI (amenorrhea > 4 months or spaniomenorrhea > 4 months and FSH > 25 IU/L checked twice, more than 4 weeks apart)
  • absence of hormonal treatment,
  • patient's oral consent,
  • affiliated or beneficiary of health insurance

Who cannot take part

  • contraindication to hormonal treatment (history of hormone-dependent cancer, history of ischemic arterial stroke),
  • inability of the patient to understand the nature or risks or significance and implications of the clinical investigation,
  • patient under legal protection

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to evaluate the evolution of quality of sex life of women with POI after introduction hormone replacement therapy through the FSFI scale

The group in the trial

  • QuestionnairesTreatment being tested

    Female Sexual Function Index (FSFI) and WHO Quality of Life-BREF (WHOQOL-BREF) questionnaires at baseline and at 6 months after starting hormone replacement therapy.

    Treatment: questionnaire

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 June 2026